Atlas Trials

Study of BHV-1300 in Graves' Disease

Clinical trial NCT06980649 · RECRUITING

Trial details

NCT number
NCT06980649
Sponsor
Biohaven Therapeutics Ltd.
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Graves Disease
Start date
2025-08-21
Primary completion
2027-09-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.